（旧版）「喘息ガイドライン作成に関する研究」平成11年度研究報告書/ガイドライン引用文献(2000年まで)簡易版抄録を掲載

参考文献

1. National Institutes of Health , National Heart Lung, and Blood Institute. Global Strategy for Asthma Management and Prevention . NHLBI / WHO workshop report (chairman : Sheffer A) , March 1993. NIH Publication 1995; 95 - 3659.
2. Bergner M , et al. The Sickness Impact Profile : development and final revision of a health status measure . Med Care 1981; 19 : 787 - 805.
3. Schumacher M , et al. Assessment of quality of life in clinical trials . Stat Med 1991 ; 10 : 1915 - 1930.
4. Stewart AL , Hays RD , Ware JE Jr. The MOS short - form general health survey-Reliability and validity in a patient population . Med Care 1988 ; 26 : 724 - 735.
5. Juniper EF , et al. Evaluation of impairment of health related quality of life in asthma - development of a questionnaire for use in clinical trials . Thorax 1992 ; 47 : 76 - 83
6. Hyland ME , Finnis S , Irvine SH. A scale for assessing quality of life in adult asthma sufferers . J Psychosom Res 1991 ; 35 : 99 - 110.
7. Bender BG. Measurement of quality of life in pediatric asthma clinical triais . Ann Allergy Asthma Immunol 1996 ; 77 : 438-447.
8. Malo JL, Cartier A, Cote J, et al. Influence of inhaled steroids on recovery from occupational asthma after cessation of exposure: an 18-month double-blind crossover study. Am J Respir Crit Care Med 1996; 153: 953-60. (評価 II,A)
9. Malmstrom K.Rodriguez-Gomez G, Guerra J, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Ann Int Med 1999; 130: 487-95. (評価 II,A)
10. Juniper EF, Buist AS. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group. Chest 1999; 116: 1297-303. (評価 II,A)
11. Okamoto LJ, Noonan M, DeBoisblanc BP, et al. Fluticasone propionate improves quality of life in patients with asthma requiring oral corticosteroids. Ann Allergy Asthma Immunol 1996; 76:455-61. (評価 II,A)
12. Mahajan P, Okamoto LJ, Schaberg A, et al. Impact of fluticasone propionate powder on health-related quality of life in patients with moderate asthma. J Asthma 1997; 34: 227-34. (評価 II,A)
13. Mahajan P, Pearlman D, Okamoto L. The effect of fluticasone propionate on functional status and sleep in children with asthma and on the quality of life of their parents. J Allergy Clin Immunol 1998; 102: 19-23. (評価 II,A)
14. Sheikh S, Goldsmith LJ, Howell L, et al. Comparison of the efficacy of inhaled fluticasone propionate, 880 microg/day, with flunisolide, 1500 microg/day, in moderate-to-severe persistent asthma. Ann Allergy Asthma Immunol 1999; 83: 300-4. (評価 II-A)
15. McFadden ER, Casale TB, Edwards TB, et al. Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma. J Allergy Clin Immunol 1999; 104: 46-52. (評価 II,A)
16. van Schayck CP, Dompeling E, Rutten MP, et al. The influence of an inhaled steroid on quality of life in patients with asthma or COPD. Chest 1995; 107: 1199-205. (評価 II,B)
17. Israel E, Cohn J, Dub L, et al. Effect of treatment with zileuton, a 5 - lipoxygenase inhibitor, in patients with asthma : a randomized controlled trial. JAMA 1996; 275: 931-936. (評価 II,A)
18. Schwartz HJ, Petty T, Dub LM, et al. A randomized controlled trial comparing zileuton with theophylline in moderate asthma. The Zileuton Study Group . Arch Intern Med 1998;158 : 141- 148. (評価 II,A)
19. Nathan RA, Bernstein JA, Bielory L, et al. Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction. J Allergy Clin Immunol 1998; 102 : 935-942. (評価 II,A)
20. Reiss TF, Chevinsky P, Dockhorn RJ, et al. Montelukast, a once dairly leukotriene recepor antigonist, in the treatment of chronic asthma. Arch Int Med 1998 ; 158 : 1213 - 1220. (評価 II,A)
21. Noonan MJ, Chervinsky P, Brandon M, et al. Montelukast, a potent leukotriene receptor antagonist, causes does - related improvements in chronic asthma . Eur Resp J 1998; 11 : 1232- 1239. (評価 II,A)
22. Malmstrom K, Gomez GR, Guerra J, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma : a randomized controlled trial . Ann Int Med 1999; 130: 487-495. (評価 II,A)
23. van Molken MP, Clusters F, van Doorslaer EKA., et al. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respir J 1995; 8:888-898. (評価 II,A)
24. Juniper EF, Johnston PR, Borkhoff CM, et al. Quality of life in asthma clinical trials:comparison of salmeterol and salbutamol. Am J Respir Crit Care Med 1995; 155: 66-70. (評価 II,A)
25. Sally EW, William L, Michael M, et al . Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patientswith mild to moderate persistent asthma . Ann Allergy Asthma Immunol 1998; 80: 463 - 470. (評価 II,A)
26. James PK, David AC, Gary AI, et al. Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. J Allergy Clin Immunol 1998 ;101: 188 - 195. (評価 II,A)
27. Richard FL., Lawrence MD, Bruce F, et al . Nocturnal asthma : effect of salmeterol on quality of life and clinical outcomes. Chest 1999; 115 : 666 - 673. (評価 II,A)
28. Laurel W, Cathy NM, Grazyna Z, et al . Salmeterol vs theophylline : sleep and efficacy outcomes in patients with noctural athma. Chest 1999;115 : 1525 - 1532. (評価 II,A)
29. van der Molen, T, Sears MR, de Graaff CS, et al. Quality of life during formoterol treatment: comparison between asthma-specific and generic questionnaries . Eur. Respir. J., 1998; 12: 30-34. (評価 II,C)
30. Corren J, Harris AG, Aaronson D, et al. Efficacy and safety of loratadine plus psuedoephedrine in patients with seasonal allergic rhinits and mild asthma . J Allergy Clin Immunol 1997; 100 : 781 - 788. (評価 II,A)
31. Kuitert LM, Angus RM, Barnes NC, et al. Effect of a novel platelet - activating factor antagonist , modipafant , in clinical asthma . Am J Respir Crit Care Med 1995; 151 : 1331 - 1335. (評価 II,C)
32. Jones PJ, and the nedcromil sodium QOL study group . Quality of life , symptoms and pulmonary function in asthma : long - term treatment with nedcromil sodium examined in a controlled multicentre trial. Eur Respir J 1994; 7: 55 - 62. (評価 II-A)